APVO — Aptevo Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-Nordstrom, Gap, HP Inc, Chevron
U.S. STOCKS ON THE MOVE-HP Inc, Gap Inc, Nordstrom, Qualcomm
U.S. STOCKS ON THE MOVE-Zoom, Gap Inc, Chevron
Aptevo falls after record gains day before, retail interest persists
U.S. STOCKS ON THE MOVE-Zoom, Tesla, Chevron
U.S. STOCKS ON THE MOVE-Apple, Netflix, Dollar Tree, Alibaba Group
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:00 PM
Aptevo surges after cancer patient achieves complete remission in trial
Brief: Aptevo Therapeutics Inc- Preliminary Data Observed To Date From Phase 1B Expansion Trial Evaluating APVO436 Includes One Complete Remission
Brief: Aptevo Therapeutics Reports Qtrly Loss Per Share of $1.43
Brief: Aptevo Therapeutics Inc Files Prospectus Related To Resale Of Up To 1,250,000 Shares Of The Common Stock
Aptevo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Aptevo Therapeutics drops after investment fund withdraws buyout bid
Brief: Aptevo Therapeutics Announces Expansion Phase Of Lead Anti-Leukemia Drug Apvo436 In Adult Patients With Acute Myeloid Leukemia
U.S. STOCKS ON THE MOVE-Sabre Corp, GameStop, Red Robin Gourmet Burgers
Aptevo Therapeutics hits near 1-mth high on positive leukemia drug trial data
Brief: Aptevo Therapeutics Inc Says Qtrly Royalty Revenue Was $2.4 Million
Brief: Tang Capital Partners Says Submitted Two Director Nominees And Advisory Proposal For Consideration At Aptevo Therapeutics’ 2021 Annual Meeting
Brief: Aptevo Therapeutics Inc Files For Offering Of $200 Million Mixed Shelf